• Contact Us
PAVmed Inc. - Innovating at the speed of life. PAVmed Inc. - Innovating at the speed of life.
  • Home
  • Company
    • About Us
    • Business Model
    • Leadership
    • Board of Directors
    • Medical Advisory Board
    • Careers
  • Products
    • EsoCheck
    • EsoGuard
    • CarpX
    • PortIO
    • DisappEAR
    • Future Innovations
  • Investor Relations
  • Contact
PAVmed Inc. - Innovating at the speed of life.
  • Home
  • Company
    • About Us
    • Business Model
    • Leadership
    • Board of Directors
    • Medical Advisory Board
    • Careers
  • Products
    • EsoCheck
    • EsoGuard
    • CarpX
    • PortIO
    • DisappEAR
    • Future Innovations
  • Investor Relations
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • NASDAQ: PAVM
    • NASDAQ: PAVMZ
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity Matrix
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts

Lucid Diagnostics Provides Updates on Newly Published Esophageal Precancer Clinical Guideline and Proposed Medicare Local Coverage Determination

Apr 04, 2022 8:25am EDT

Lucid Diagnostics to Participate in the Needham 21st Annual Healthcare Conference

Mar 30, 2022 8:25am EDT

PAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results

Mar 29, 2022 4:11pm EDT

Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results

Mar 28, 2022 4:47pm EDT

PAVmed Subsidiary Lucid Diagnostics Announces Launch of VA EsoGuard® Study

Mar 24, 2022 8:25am EDT

PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers

Mar 23, 2022 8:25am EDT

PAVmed Announces Successful First-in-Human Implantations of its PortIO™ Intraosseous Infusion System

Mar 17, 2022 8:25am EDT

PAVmed Subsidiary Veris Health Launches World-Class Technology Advisory Board

Mar 10, 2022 8:25am EST

PAVmed to Hold a Business Update Conference Call on March 29, 2022

Mar 08, 2022 8:30am EST

Lucid Diagnostics to Hold a Business Update Conference Call on March 28, 2022

Mar 07, 2022 8:30am EST
RSS
  • Prev
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...23
    Next
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed

    About PAVmed Inc.

    PAVmed Inc. (Nasdaq:PAVM) is a highly-differentiated, multi-product medical device company employing a unique and proven business model designed to advance products from concept to commercialization much more rapidly and with significantly less capital than the typical medical device company. This model enables us to pursue an expanding pipeline strategy with a view to enhancing and accelerating value creation.

    Follow Us

    PAVmed Inc

    One Grand Central Place, Suite 4600
    New York, NY 10165
    212-949-4319
    info@pavmed.com


    PAVmed Inc. - Innovating at the speed of life.
    © Copyright 2023. All Rights Reserved by PAVmed Inc. .
    • News
    • Contact
    • Privacy Policy
    For more information regarding the proposed terms of settlement of a pending class action lawsuit, please click here.